Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Cash & Equivalents: 2011-2025

Historic Cash & Equivalents for SRx Health Solutions (SRXH) over the last 12 years, with FY2025 value amounting to $1.3 million.

  • SRx Health Solutions' Cash & Equivalents rose 113490.57% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year increase of 113490.57%. This contributed to the annual value of $1.3 million for FY2025, which is N/A changed from last year.
  • As of FY2025, SRx Health Solutions' Cash & Equivalents stood at $1.3 million.
  • SRx Health Solutions' 5-year Cash & Equivalents high stood at $28.9 million for FY2021, and its period low was $1.3 million during FY2025.
  • Its 5-year average for Cash & Equivalents is $9.4 million, with a median of $4.5 million in 2023.
  • Per our database at Business Quant, SRx Health Solutions' Cash & Equivalents surged by 63718.8% in 2021 and then tumbled by 6726.9% in 2022.
  • Annual analysis of 5 years shows SRx Health Solutions' Cash & Equivalents stood at $28.9 million in 2021, then plummeted by 67.27% to $9.5 million in 2022, then crashed by 52.97% to $4.5 million in 2023, then crashed by 31.18% to $3.1 million in 2024, then tumbled by 57.31% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in FY2025, $3.1 million for FY2024, and $4.5 million during FY2023.